NAD Injections: Claimed Benefits, Real Risks and UK Regulatory Status

Nicotinamide adenine dinucleotide (NAD+) injections are being offered at a growing number of private wellness clinics across the UK, marketed for everything from chronic fatigue to anti-ageing and addiction recovery support. The science behind NAD+ as a coenzyme is genuinely interesting. The clinical evidence for injecting it, however, is a different matter.

This article sets out what NAD+ actually does in the body, what the proposed benefits are and where the evidence stands, the regulatory status of these injections in the UK, and the practical things you should know before spending money on a course of treatment.

What NAD+ Does in the Body#

NAD+ is a coenzyme present in every living cell. It plays a central role in redox reactions that convert nutrients into ATP, the molecule your cells use for energy. Without it, mitochondrial function collapses. It also acts as a cofactor for sirtuins, a family of proteins involved in DNA repair, inflammation regulation, and cellular stress responses, and for poly(ADP-ribose) polymerases (PARPs), which are enzymes critical to repairing damaged DNA.

NAD+ levels decline naturally with age. Research published in Nature Metabolism has shown this decline is associated with a range of age-related physiological changes, though causation versus correlation remains an active area of investigation. The theoretical appeal of restoring NAD+ levels is therefore understandable, even if the clinical application is still far ahead of the supporting evidence.

NAD injections are administered either intramuscularly (IM) or intravenously (IV). The IV route delivers NAD+ directly into the bloodstream; IM administration delivers it into muscle tissue, where it is absorbed into circulation more gradually. Proponents argue that injectable routes offer higher bioavailability than oral supplements, but human pharmacokinetic data on how injected NAD+ is distributed, metabolised, and how long any increase in cellular NAD+ levels actually persists is not well characterised. That matters when evaluating clinical claims.

The Proposed Benefits and What Evidence Exists#

The benefits marketed by private clinics fall into several broad categories. It is worth being honest about where the evidence sits for each.

Energy and Fatigue#

This is the most commonly cited reason people seek NAD injections. The logic is straightforward: NAD+ is central to mitochondrial ATP production, so supplementing it should improve cellular energy output and reduce fatigue. Some people report meaningful subjective improvements. The difficulty is that without placebo-controlled trials, it is impossible to separate genuine pharmacological effect from expectation. No large randomised controlled trials have established NAD injections as an evidence-based treatment for fatigue in humans.

If you are experiencing persistent unexplained fatigue, the NHS recommends proper investigation before pursuing any complementary therapy. NICE guidance on ME/CFS (NG206) sets out a comprehensive assessment pathway, and initial bloods typically cover full blood count, thyroid function, HbA1c, ferritin, B12, folate, and inflammatory markers. These investigations rule out treatable causes like anaemia, hypothyroidism, and diabetes, all of which are far better supported by evidence than NAD injections.

Cognitive Function#

Animal studies suggest NAD+ supports neuronal health and may have neuroprotective properties. One study found that nicotinamide mononucleotide (an NAD+ precursor) protected against beta-amyloid-induced cognitive impairment in a rodent model. The leap from rodent models to human cognitive enhancement is a long one, and no robust human RCTs support the use of NAD injections for memory, focus, or neurodegenerative conditions. The evidence here is preclinical, not clinical.

Metabolic Health#

NAD+ influences glucose and lipid metabolism, and some animal studies suggest NAD+ precursors may improve insulin sensitivity. Research on diabetic peripheral neuropathy and NAD+ has shown some early signals, but translation to human metabolic disorders via IV or IM NAD+ specifically remains unproven. Importantly, evidence from oral NAD+ precursor studies (nicotinamide riboside or NMN) should not be extrapolated directly to injected NAD+, as they are different interventions with different pharmacokinetics.

Anti-Ageing and Cellular Repair#

This is where marketing language tends to outrun the science most aggressively. NAD+'s role in sirtuin activation and DNA repair is real at a cellular biology level. Whether injecting NAD+ into a middle-aged adult meaningfully reverses or slows ageing processes is an entirely different question. Current evidence does not support this claim in humans. Lifestyle interventions, including regular physical activity, a Mediterranean-pattern diet, adequate sleep, and not smoking, remain the only interventions with robust evidence for longevity and healthy ageing.

Addiction Recovery Support#

Some private clinics offer NAD therapy as a complementary support during withdrawal from alcohol or opioids, citing anecdotal reports of reduced cravings. NICE guidelines for drug and alcohol misuse treatment do not include NAD therapy, and anyone seeking help with substance dependence should access evidence-based support through NHS drug and alcohol services or via the FRANK helpline (www.talktofrank.com). Complementary therapies should never replace these pathways.

NAD Injections versus Oral NAD+ Supplements#

Before committing to injectable treatment, it is worth understanding the alternative. Oral NAD+ precursors, particularly nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), are legally available as food supplements without prescription and have a broader (though still limited) base of human clinical trial data than injectable NAD+.

Oral supplements are considerably cheaper, carry no injection-related risks, and are more accessible. The argument for injectable administration is largely theoretical bioavailability advantage, but this has not been demonstrated to translate into meaningfully better clinical outcomes in humans. For most people curious about NAD+ supplementation, oral precursors are a more proportionate starting point than a course of IV infusions.

UK Regulatory Status: What the MHRA Says#

This is important, and it is something many clinic websites underplay. NAD injections are not licensed medicines in the UK. The MHRA has not evaluated them for safety, efficacy, or quality through the standard marketing authorisation process.

They are supplied as unlicensed medicines, known in the UK as 'specials'. Under the MHRA's specials framework, an unlicensed medicine can be legally supplied when prescribed by an appropriate prescriber on a patient-specific basis where no licensed equivalent exists. This is a legitimate but more limited regulatory pathway than full marketing authorisation. It means there are no standardised doses or formulations, quality can vary between suppliers, and the long-term safety profile has not been established through the rigorous trials required for a licensed medicine.

For patients, this means informed consent is particularly important. Before accepting a prescription for an unlicensed special, you should be clearly told it is unlicensed, what the known and unknown risks are, and that any adverse reactions should be reported to the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

Any clinic offering NAD injections should be registered with the appropriate regulator: the Care Quality Commission (CQC) in England, Healthcare Improvement Scotland (HIS), Healthcare Inspectorate Wales (HIW), or the Regulation and Quality Improvement Authority (RQIA) in Northern Ireland. Practitioners should hold registration with the GMC, NMC, HCPC, or GPhC. It is reasonable, and sensible, to verify this before booking.

Side Effects and Safety Considerations#

Because large-scale controlled trials have not been conducted, the safety profile of NAD injections is not comprehensively characterised. The following side effects are reported anecdotally and through post-marketing observations:

• Injection site reactions: pain, redness, bruising, or swelling at the IM site
• Flushing and warmth: common with IV administration, likely due to vasodilation
• Nausea and gastrointestinal discomfort: mild digestive upset during or after infusion
• Headache and dizziness: particularly with rapid IV administration
• Temporary fatigue or restlessness: paradoxically reported by some patients in the hours following treatment

IV-specific risks include thrombophlebitis (vein inflammation), infection at the cannula site, extravasation of fluid into surrounding tissue, and, rarely, air embolism. Anaphylactic reactions are possible with any injectable product. Reputable clinics should have resuscitation equipment available and staff trained to manage anaphylaxis.

Infusion rate matters significantly for IV NAD+. Rapid administration is associated with chest tightness, flushing, and anxiety-like symptoms. Most experienced practitioners administer IV NAD+ slowly over several hours to reduce this risk.

People who should be particularly cautious or who should avoid NAD injections include:

• Those with active malignancy (theoretical concerns about supporting cancer cell metabolism)
• People with cardiovascular conditions (effects on blood pressure and heart rate are not fully characterised)
• Those who are pregnant or breastfeeding (no safety data exists)
• Children and adolescents under 18 outside of clinical trial settings
• Individuals with severe liver or kidney impairment

Drug interactions with NAD+ have not been systematically studied. Theoretical concerns exist around interactions with chemotherapy agents (given NAD+'s role in PARP activation and DNA repair pathways), anticoagulants, and medications affecting metabolic enzymes. If you take regular prescription medication, speak to your GP or a pharmacist before pursuing this treatment.

Questions to Ask Before Booking a Clinic#

If you are seriously considering NAD injection therapy after weighing the evidence limitations, these are the questions worth asking any private clinic before committing:

1. Is the clinic registered with the CQC (or equivalent regulator in Scotland, Wales, or Northern Ireland)? Can you provide your registration number?
2. What professional registration does the prescriber hold (GMC, NMC, GPhC, HCPC)?
3. Where is the NAD+ sourced from? Is the manufacturer GMP-certified?
4. Can I see the batch number and sterility certificate for the product before treatment?
5. Will I receive a written prescription and informed consent documentation?
6. What is the protocol if I have an adverse reaction during or after the infusion?
7. Is there resuscitation equipment on site and staff trained in anaphylaxis management?
8. What follow-up is provided as part of the treatment package?

A reputable clinic should be able to answer all of these without hesitation. Evasiveness on any of them is a red flag.

Indicative Costs and What to Budget For#

NAD injections are not available on the NHS and are not eligible for reimbursement. Private treatment costs vary considerably depending on the route of administration, dose, clinic location, and whether you are purchasing individual sessions or a course.

As a rough guide, single IV NAD+ infusion sessions typically range from £150 to £400, with some premium London clinics charging more. Treatment courses (often sold as four to ten sessions) are frequently priced between £800 and £2,500. IM injections are generally cheaper per session than IV infusions but are also less well-studied. These costs are not trivial, particularly given the evidence base for clinical benefit remains limited.

A Realistic Summary#

NAD+ is a genuinely important molecule in human biology. The science of NAD+ decline with ageing is real and interesting. The commercial wellness application of injecting it is considerably ahead of the clinical evidence.

For most people investigating NAD injections, the honest advice is to ensure any treatable underlying cause of fatigue, cognitive symptoms, or metabolic concerns has been properly investigated through your GP first. Lifestyle interventions with a strong evidence base should form the foundation of any longevity or energy-optimisation strategy. If you are interested in NAD+ supplementation specifically, oral precursors such as NR or NMN are a lower-risk, lower-cost starting point than injectable therapy.

If you do choose to pursue NAD injections, do so through a properly registered clinic with qualified practitioners, insist on informed consent documentation, and report any adverse reactions to the MHRA Yellow Card Scheme.

For other evidence-based treatments available through properly regulated UK pharmacy channels, including licensed weight management medications, Totiva offers pharmacist-led online consultations through our weight loss service. If managing your metabolic health or fatigue has led you to explore multiple options, speaking to a pharmacist who can review your full picture is often the most useful place to start.